DUBLIN--(BUSINESS WIRE)--The "Peripheral Vascular Devices Market Report, Forecast by Device Type, Country and Company Analysis 2024-2032" report has been added to ResearchAndMarkets.com's offering.
The U.S. FDA has finalized a guidance for class II devices for treatment of peripheral artery disease that excludes drug-coated balloons (DCBs), which are regulated as class III devices. One of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback